Process for assembly of POSS monomers

Information

  • Patent Grant
  • 7485692
  • Patent Number
    7,485,692
  • Date Filed
    Tuesday, March 7, 2006
    18 years ago
  • Date Issued
    Tuesday, February 3, 2009
    15 years ago
Abstract
A synthesis process for polyhedral oligomeric silsesquioxanes using phosphazene superbases to produce in high yield a low resin content, solvent free, and trace metal free monomer suitable for use in microelectronic, biological, and medical applications involving polymerization, grafting, and alloying.
Description
FIELD OF THE INVENTION

This invention relates generally to a process for enhancing the properties of functionalized POSS monomers for incorporation into polymeric and biological products.


BACKGROUND OF THE INVENTION

Nanostructured chemicals are best exemplified by those based on low-cost Polyhedral Oligomeric Silsesquioxanes (POSS) and Polyhedral Oligomeric Silicates (POS). POSS systems contain hybrid (i.e. organic-inorganic) compositions in which the internal cage like framework is primarily comprised of inorganic silicon-oxygen bonds. The exterior of the nanostructure is covered by both reactive and nonreactive organic functionalities (R), which ensure compatibility and tailorability of the nanostructure with organic monomers and polymers. These and other properties and features of nanostructured chemicals are discussed in detail in U.S. Pat. No. 5,412,053 and U.S. Pat. No. 5,484,867, both of which are expressly incorporated herein by reference in their entirety.


Current-engineering practices produce functionalized POSS molecules in high yield but certain microelectronic, medical, and biological applications require higher-purity or chemical functionalities that are not readily or economically produced using the prior art. Prior art methods include the use of hydroxide base, anionic salts, and protic, acid catalysts in the assembly of POSS cages and their functionalization (see U.S. patent application Ser. Nos. 09/631,892 and 10/186,318, and U.S. Pat. Nos. 6,770,724; 6,660,823; 6,596,821; and 3,390,163). While these approaches are known to be generally effective, they are limited in that both protic acids and hydroxide bases can also catalyze the self-condensation of POSS individual cages into oligomerized POSS cage containing resins (FIG. 1). Such resins are not desirable in microelectronics, biological or medical applications, as their structure is molecularly imprecise. Furthermore, the dispersion of the POSS molecules and their compatibility with polymers is thermodynamically governed by the free energy of mixing equation (ΔG=ΔH−TΔS). The nature of the R group and ability of the reactive groups on the POSS cage to react or interact with polymers and surfaces greatly contributes to a favorable enthalpic (ΔH) term while the entropic term (ΔS) for POSS is highly favorable when the cage size is monoscopic and the corresponding distribution of oligomers is 1.0.


Consequently a need exists for improvement upon the prior art methods of POSS cage assembly and functionalized monomers. An improved process yielding, higher purity, and molecularly precise POSS systems is described.


SUMMARY OF THE INVENTION

The present invention provides an improved synthesis process for polyhedral oligomeric silsesquioxanes which produces rapidly, in high yield, low resin content, and solvent free, monomer products suitable for use in polymerization, grafting and alloying applications. The synthesis process uses phosphazene superbases in reaction with silane coupling agents of the formula R1SiX3 to form POSS cages functionalized with silanols of the formula types [(R1SiO1.5)7(HOSiO1.5)1]Σ8, [(R1SiO1.5)6(R1HOSiO1)2]Σ8, [(R1SiO1.5)2(R1HOSiO1)4]Σ6, [(R1SiO1.5)4(R1HOSiO1)3]Σ7. The synthesis process can also involve the reaction of phosphazene superbases in reaction with silane coupling agents of the type R2SiX3 to form polyfunctional POSS cages functionalized with R2 groups of the formula types [(R2SiO1.5)6]Σ6, [(R2SiO1.5)8]Σ8, [(R2SiO1.5)10]Σ10, [(R2SiO1.5)12]Σ12 and larger sized cages.


Alternately the phosphazene superbases can be reacted with POSS silanols of the formula [(R1SiO1.5)7(HOSiO1.5)1]Σ8, [(R1SiO1.5)6(R1HOSiO1)2]Σ8, [(R1SiO1.5)4(R1HOSiO1)3]Σ7 in the presence of a silane coupling agent of the formula R2R3R4SiX, R2R3SiX2, or R2SiX3 for sufficient time in the presence of a solvent and superbase where the elimination of HX occurs and renders a monofunctional POSS monomer of the formula [(R1SiO1.5)8(R2R3R4SiO1)]Σ9, [((R1SiO1.5)8)2(R2R3SiO2)]Σ17, [((R1SiO1.5)8)3(R2SiO3)]Σ25, [(R1SiO1.5)6(R1SiO1.5)2(R2R3R4SiO)2]Σ10, [(R1SiO1.5)6(R1SiO1)2(R2R3SiO2)]Σ9, [(R1SiO1.5)6(R1HOSiO1)1(R2R3SiO)]Σ8, [(R1SiO1.5)6(R1(R2R3R4SiO)SiO1)(R2R3SiO)]Σ9, [(R1SiO1.5)4(R1(R2R3R4SiO)SiO1)3]Σ10, [(R1SiO1.5)7(R2SiO1.5)1]Σ8, respectively. The resulting monomer is essentially free of impurities and has controllable properties through selection of composition, R groups, and nanostructure size and topology. Highly purified nanostructured POSS monomers are desirable as they exhibit improved filtration capability, reduced contamination and viscosity, more reliable polymerization, lower cost and waste reduction over impure systems.


A preferred process involves the reaction of POSS silanols of the formula [(R1SiO1.5)7(HOSiO1.5)1]Σ8, [(R1SiO1.5)6(R1HOSiO1)2]Σ8, [(R1SiO1.5)4(R1HOSiO1)3]Σ7 with a silane coupling agent of the formula, R2R3R4SiX, R2R3SiX2, R2SiX3 in the presence of a solvent and superbase.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows a comparison of the prior art and improved silation process;



FIG. 2 shows a variety of the preferred phosphazene superbases; and



FIG. 3 shows the structure of the compound synthesized in Example 5.





DEFINITION OF FORMULA REPRESENTATIONS FOR NANOSTRUCTURES

For the purposes of understanding this invention's chemical compositions the following definition for formula representations of Polyhedral Oligomeric Silsesquioxane (POSS) and Polyhedral Oligomeric Silicate (POS) nanostructures is made.


Polysilsesquioxanes are materials represented by the formula [RSiO1.5] where ∞ represents molar degree of polymerization and R=represents organic substituent (H, siloxy, cyclic or linear aliphatic or aromatic groups that may additionally contain reactive functionalities such as alcohols, esters, amines, ketones, olefins, ethers or halides or which may contain fluorinated groups). Polysilsesquioxanes may be either homoleptic or heteroleptic. Homoleptic systems contain only one type of R group while heteroleptic systems contain more than one type of R group.


POSS and POS nanostructure compositions are represented by the formula:

[(RSiO1.5)n]Σ# for homoleptic compositions
[(RSiO1.5)n(R′SiO1.5)m]Σ# for heteroleptic compositions (where R≠R′)
[(RSiO1.5)n(RXSiO1.0)m]Σ# for functionalized heteroleptic compositions (where R groups can be equivalent or in equivalent)


In all of the above R is the same as defined above and X includes but is not limited to OH, Cl, Br, I, alkoxide (OR), formate (OCH), acetate (OCOR), acid (OCOH), ester (OCOR), peroxide (OOR), amine (NR2) isocyanate (NCO), and R. The symbols m and n refer to the stoichiometry of the composition. The symbol Σ indicates that the composition forms a nanostructure and the symbol # refers to the number of silicon atoms contained within the nanostructure. The value for # is usually the sum of m+n, where n ranges typically from 1 to 24 and m ranges typically from 1 to 12. It should be noted that Σ# is not to be confused as a multiplier for determining stoichiometry, as it merely describes the overall nanostructural characteristics of the system (aka cage size).


DETAILED DESCRIPTION OF THE INVENTION

The present invention teaches an improved method of synthesis for POSS nanostructured chemicals yielding a higher purity and lower cost product than previously described.


The key feature of the invention is the use of phosphazene superbases to catalyze the assembly of POSS cages. A range of phosphazenes are applicable and include polyphosphazenes which vary in molecular weight and composition. Phosphazene oligomers and molecules are preferentially utilized and in particular P1 type P(NtBu)(NH2)3, P2 type (H2N)3P═N—P(NH2)4, P3 type (H2N)3P═N—P(NH2)—N═P(NH2)3, P4 type (H2N)3P═N—P(NH2)3═N—P(NH2)3—N═P(NH2)3. The basicity of phosphazene superbases increase with increasing number of phosphorous atoms and this provides a valuable tool in the utility of this reagent. The preferred concentration of superbase relative to trisilanol is 2 mol % but a useful range includes 0.1 mol % to 10 mol %.


General Process Variables Applicable To All Processes


As is typical with chemical processes there are a number of variables that can be used to control the purity, selectivity, rate and mechanism of any process. Variables influencing the process include the size, polydispersity, and composition of the nanostructured chemical, separation and isolation methods, and use of catalyst or cocatalysts, solvents and cosolvents. Additionally, kinetic and thermodynamic means of controlling the synthesis mechanism, rate, and product distribution are also known tools of the trade that can impact product quality and economics.


EXAMPLE 1
Synthesis of [(isobutylSiO1.5)7(methacrylpropylSiO1.0)1]Σ8

[(isobutylSiO1.5)4(isobutyl(OH)SiO1.0)3]Σ7 (688 g, 0.87 mole) was dissolved in THF followed by addition of methacrylpropyltrimethoxysilane (204 g, 0.87 mole) and the solution was cooled to 5° C. Phosphazene superbase (FW 234.32, 15.72 mmol) was then added and the mixture stirred at room temperature for 3 days. The solution was then quenched with acetic acid (1.5 g). Then 1 liter of methanol was added and the mixture was stirred and filtered. The solid was dried to render pure white product in 75% yield.


EXAMPLE 2
Synthesis of [(EtSiO1.5)7(glycidalSiO1.0)1]Σ8

[(EtSiO1.5)4(Et(OH)SiO1.0)3]Σ7 (50 g, 84 mmole) was dissolved in methanol followed by addition of 3-glycidoxypropyltrimethoxysilane (19.86 g, 84 mmole) and the solution was cooled to 5° C. Phosphazene superbase (FW 234.32, 15.72 mmol) was then added and the mixture stirred for 3 days at 5° C. The solution was then quenched with acetic acid (87 mg) filtered, and volatiles removed and dried to render a solid. The solid washed with methanol (1400 ml) and dried to render 415 g of pure white product in 87% yield.


EXAMPLE 3
Synthesis of [(EtSiO1.5)7(ethylnorborneneSiO1.0)1]Σ8

[(EtSiO1.5)4(Et(OH)SiO1.0)3]Σ7 (12 g, 20 mmole) was dissolved in methanol followed by addition of exo-norbornenylethyltrimethoxysilane (4.84 g, 20 mmole) and the solution was cooled to 5° C. Phosphazene superbase was then added and the mixture stirred for 2 days at 5° C. The solution was then quenched with acetic acid (87 mg) filtered, and volatiles removed, washed with additional methanol and dried to render a white product.


EXAMPLE 4
Synthesis of [(CyclohexylSiO1.5)7(aminoethylaminpropylSiO1.0)1]Σ8

[(CyclohexylSiO1.5)4(Cyclohexyl(OH)SiO1.0)3]Σ7 (10 g, 10.3 mmole) was dissolved in THF followed by addition of 3-(N-aminoethyl)aminopropyltrimethoxysilane (2.32 g, 10.27 mmole) and phosphazene superbase (FW 234.32, 15.72 mmol) was then added and the mixture stirred at room temperature. The solution was then quenched with acetic acid methanol was added. The volatiles were removed and product dried to render a pure white solid in 62% yield.


EXAMPLE 5
Synthesis of [(PhenylSiO1.5)7(aminopropylSiO1.0)1]Σ8

[(PhenylSiO1.5)4(Phenyl(OH)SiO1.0)3]Σ7 (5.9 g, 6.3 mol) was dissolved in toluene followed by addition of (2.0 g, 11 mmol) 3-aminopropyltrimethoxysilane and was then stirred at room temperature for 12 hours. Acetonitrile was added and the solution was filtered and product dried to render a pure white solid in 40% yield.


While certain representative embodiments and details have been shown for purposes of illustrating the invention, it will be apparent to those skilled in the art that various changes in the methods and apparatus disclosed herein may be made without departing from the scope of the invention which is defined in the appended claims.

Claims
  • 1. A method for preparing functionalized POSS monomers comprising the step of reacting a silane coupling agent having the formula RSiX3 in the presence of a solvent and a phosphazene superbase, wherein: R is selected from the group consisting of hydrogen, siloxy, and aliphatic, aromatic, and olefinic groups, wherein said groups may contain reactive functionalities selected from the group consisting of alcohols, esters, amines, ketones, olefins, ethers, and halides, and may contain fluorinated subtituents;X is selected from the group consisting of OH, CI, Br, I, alkoxide (OR), formate, acetate (OCOR), acid (OCOH), ester (OCOR), peroxide (OOR), amine (NR2), isocyanate (NCO), and R; andeach R and each X may be the same or different.
  • 2. The method of claim 1, wherein the superbase is selected from the group consisting of P1, P2, P3, and P4 type phosphazenes.
  • 3. The method of claim 1, wherein a mixture of different silane coupling agents are reacted are utilized to prepare functionalized POSS monomers.
  • 4. The method of claim 1, wherein a mixture of different superbases are utilized as homogeneous catalysts or coreagents.
  • 5. The method of claim 1 wherein a mix of different solvents or reaction media are utilized.
  • 6. The method of claim 1 wherein a continuous process rendering functionalized POSS monomers is utilized that uses the superbase as a heterogeneous catalyst or coreagent.
  • 7. A method for preparing functionalized POSS monomers comprising the step of silating a POSS silanol with a silane coupling agent having the formula selected from the group consisting of RSiX3, R2SiX2, and R3SiX in the presence of a solvent and a phosphazene superbase, wherein: R is selected from the group consisting of hydrogen, siloxy, and aliphatic, aromatic, and olefinic groups, wherein said groups may contain reactive functionalities selected from the group consisting of alcohols, esters, amines, ketones, olefins, ethers, and halides, and may contain fluorinated substituents;X is selected from the group consisting of OH, CI, Br, I, alkoxide (OR), formate, acetate (OCOR), acid (OCOH), ester (OCOR), peroxide (OOR), amine (NR2), isocyanate (NCO), and R; andeach R and each X may be the same or different.
  • 8. The method of claim 7, wherein the superbase is selected from the group consisting of P1, P2, P3, and P4 type phosphazenes.
  • 9. The method of claim 7, wherein a mixture of different, POSS silanols and silane coupling agents are silated.
  • 10. The method of claim 7, wherein a mixture of different superbases are utilized as homogeneous catalysts or coreagents.
  • 11. The method of claim 7, wherein a mix of different solvents or reaction media are utilized.
  • 12. The method of claim 7, wherein a continuous silation process is utilized that uses the superbase as a heterogeneous catalyst or coreagent.
CROSS-REFERENCE TO RELATED APPLICATIONS AND PATENTS

This application claims priority from U.S. Provisional Patent Application Ser. No. 60/659,722 Filed Mar. 7, 2005, and is a continuation-in-part of U.S. patent application Ser. No. 11/225,607 filed Sep. 12, 2005 (which claims priority from U.S. Provisional Patent Application Ser. No. 60/608,582 filed Sep. 10, 2004), which is a continuation-in-part of U.S. patent application Ser. No. 11/166,008 filed Jun. 24, 2005, which is (a) a continuation-in-part of U.S. patent application Ser. No. 09/631,892 filed Aug. 14, 2000, now U.S. Pat. No. 6,972,312 (which claims priority from U.S. Provisional Patent Application Ser. No. 60/147,435, filed Aug. 4, 1999); (b) a continuation-in-part of U.S. patent application Ser. No. 10/351,292, filed Jan. 23, 2003, now U.S. Patent No. 6,933,345 (which claims priority from U.S. Provisional Patent Application Ser. No. 60/351,523, filed Jan. 23, 2002), which is a continuation-in-part of U.S. patent application Ser. No. 09/818,265, filed Mar. 26, 2001, now U.S. Pat, No. 6,716,919 (which claims priority from U.S. Provisional Patent App1ication Ser. No. 60/192,083, filed Mar. 24, 2000); (c) a continuation-in-part of U.S. patent application Ser. No. 09/747,762, filed Dec. 21, 2000, now U.S. Pat. No. 6,911,518 (which claims priority from U.S. Provisional Patent Application Ser. No. 60/171,888, filed Dec. 23, 1999); and (d) a continuation-in-part of U.S. patent application Ser. No. 10/186,318, filed Jun. 27, 2002, now U.S. Pat. No. 6,927,270 (which claims priority from U.S. Provisional Patent Application Ser. No. 60/301,544, filed Jun. 27, 2001).

US Referenced Citations (39)
Number Name Date Kind
2801968 Furby et al. Aug 1957 A
3231499 Smith Jan 1966 A
3247111 Oberright et al. Apr 1966 A
3278436 Dazzi Oct 1966 A
3280031 Brennan et al. Oct 1966 A
3292180 Axworthy Dec 1966 A
3340286 Schiefer et al. Sep 1967 A
3347791 Thomson et al. Oct 1967 A
3390163 Brown Jun 1968 A
3673229 Malec Jun 1972 A
4483107 Tomoyori et al. Nov 1984 A
4513132 Shoji et al. Apr 1985 A
4900779 Liebfried Feb 1990 A
4946921 Shirata et al. Aug 1990 A
5047491 Saho et al. Sep 1991 A
5047492 Weidner et al. Sep 1991 A
5190808 Tenney et al. Mar 1993 A
5412053 Lichtenhan et al. May 1995 A
5457220 Razzano Oct 1995 A
5484867 Lichtenhan et al. Jan 1996 A
5589562 Lichtenhan et al. Dec 1996 A
5830950 Katsoulis et al. Nov 1998 A
5855962 Cote et al. Jan 1999 A
5858544 Banaszak Holl et al. Jan 1999 A
5939576 Lichtenhan et al. Aug 1999 A
5942638 Lichtenhan et al. Aug 1999 A
6075068 Bissinger Jun 2000 A
6100417 Lichtenhan et al. Aug 2000 A
6245849 Morales et al. Jun 2001 B1
6245926 Charrin et al. Jun 2001 B1
6252030 Zanket et al. Jun 2001 B1
6288904 Yadav et al. Sep 2001 B1
6329490 Yamashita et al. Dec 2001 B1
6596821 Katsoulis et al. Jul 2003 B1
6660823 Lichtenhan et al. Dec 2003 B1
6770724 Lichtenhan et al. Aug 2004 B1
6927270 Lichtenhan et al. Aug 2005 B2
6972312 Lichtenhan et al. Dec 2005 B1
20030055193 Lichtenhan et al. Mar 2003 A1
Related Publications (1)
Number Date Country
20070232823 A1 Oct 2007 US
Provisional Applications (6)
Number Date Country
60659722 Mar 2005 US
60608582 Sep 2004 US
60351523 Jan 2002 US
60301544 Jun 2001 US
60171888 Dec 1999 US
60147435 Aug 1999 US
Continuation in Parts (7)
Number Date Country
Parent 11225607 Sep 2005 US
Child 11371195 US
Parent 11166008 Jun 2005 US
Child 11225607 US
Parent 10351292 Jan 2003 US
Child 11166008 US
Parent 10186318 Jun 2002 US
Child 10351292 US
Parent 09818265 Mar 2001 US
Child 10186318 US
Parent 09747762 Dec 2000 US
Child 09818265 US
Parent 09631892 Aug 2000 US
Child 09747762 US